跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack
Approved
STANDARD
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack
Stallergenes Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
12c0f5f9950ff42c
Company
Stallergenes Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
12c0f5f9950ff42c
Product Name
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack
Artg Id
233470
Artg Name
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack
Sponsor
Stallergenes Australia Pty Ltd
Company Detail Path
/organization/stallergenes-australia-pty-ltd
Artg Date
2016-04-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cf188636ee1435ccfebe4a072f88e85d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1c7b17227eceb0eed024e8909b176c9d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
12c0f5f9950ff42c
Type
Standard
Back to TGA Approvals